Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Document › Details

CRISPR Therapeutics AG. (2/21/23). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results". Zug & Boston, MA.

	Organisation	CRISPR Therapeutics AG (Nasdaq: CRSP)
	Group	CRISPR Therapeutics (Group)
	Organisation 2	Vertex Pharmaceuticals Inc. (Nasdaq: VRTX)
	Group	Vertex Pharmaceuticals (Group)
	Product	exagamglogene autotemcel (exa-cel) (formerly CTX001)
	Product 2	CTX130 allogeneic CAR T-cell therapy
	Person	Harding, Alex (CRISPR Therapeutics 202301– Head BusDev before Remix Theraepeutics + Atlas Venture)
	Person 2	Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO)

Original document
accessed by [iito] on 2023-02-27

Record changed: 2024-01-20

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

More documents for CRISPR Therapeutics (Group)

[1] CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA....
[2] CRISPR Therapeutics AG. (11/7/24). "Press Release: CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference". Zug & Boston, MA....
[3] CRISPR Therapeutics AG. (11/5/24). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results". Zug & Boston, MA....
[4] CRISPR Therapeutics AG. (8/5/24). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results". Zug & Boston, MA....
[5] CRISPR Therapeutics AG. (3/13/24). "Press Release: CRISPR Therapeutics Proposes New Appointment to the Board of Directors". Zug & Boston, MA....
[6] CRISPR Therapeutics AG. (2/13/24). "Press Release: CRISPR Therapeutics Announces $280 Million Registered Direct Offering". Zug & Boston, MA....
[7] CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z...
[8] CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA....
[9] CRISPR Therapeutics AG. (6/13/23). "Pressemitteilung: CRISPR Therapeutics to Participate in Goldman Sachs 44th Annual Global Healthcare Conference". Zug & Cambridge, MA....
[10] CRISPR Therapeutics AG. (4/13/23). "Press Release: CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference". Zug & Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)